H Majima

435 total citations
26 papers, 344 citations indexed

About

H Majima is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, H Majima has authored 26 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in H Majima's work include Cancer Treatment and Pharmacology (10 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer Research and Treatments (3 papers). H Majima is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer Research and Treatments (3 papers). H Majima collaborates with scholars based in Japan, Germany and United Kingdom. H Majima's co-authors include G. Boxer, Carl E. Shonk, A Wakui, R. N. Arison, Takao Hattori, I Urushizaki, H Ichihashi, Hisanobu Niitani, Osahiko Abe and Ryuzo Ohno and has published in prestigious journals such as The Journal of Immunology, Cancer Chemotherapy and Pharmacology and Surgery Today.

In The Last Decade

H Majima

25 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Majima Japan	8	141	98	69	59	36	26	344
E. Kurschel Germany	7	223 1.6×	115 1.2×	78 1.1×	35 0.6×	22 0.6×	15	435
Roger Mosselmans Belgium	11	161 1.1×	101 1.0×	82 1.2×	34 0.6×	45 1.3×	18	394
B. Heicke Germany	9	166 1.2×	68 0.7×	45 0.7×	47 0.8×	18 0.5×	31	372
G. Sica Italy	13	166 1.2×	123 1.3×	75 1.1×	80 1.4×	18 0.5×	43	415
Laura M. Popoviciu United States	6	139 1.0×	92 0.9×	43 0.6×	87 1.5×	21 0.6×	6	333
C S Johnson United States	9	124 0.9×	86 0.9×	76 1.1×	63 1.1×	11 0.3×	13	346
Kaoru Morishita Japan	10	163 1.2×	61 0.6×	118 1.7×	60 1.0×	21 0.6×	18	357
WR Vogler United States	12	286 2.0×	133 1.4×	76 1.1×	47 0.8×	19 0.5×	20	588
Michael S. Stahler United States	9	171 1.2×	136 1.4×	24 0.3×	52 0.9×	99 2.8×	16	454
Susumu Kajihara Japan	12	173 1.2×	86 0.9×	29 0.4×	70 1.2×	67 1.9×	17	486

Countries citing papers authored by H Majima

Since Specialization

Citations

This map shows the geographic impact of H Majima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Majima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Majima more than expected).

Fields of papers citing papers by H Majima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Majima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Majima. The network helps show where H Majima may publish in the future.

Co-authorship network of co-authors of H Majima

This figure shows the co-authorship network connecting the top 25 collaborators of H Majima. A scholar is included among the top collaborators of H Majima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Majima. H Majima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tamura, Kazuo, Hisanobu Niitani, Ryuzo Ohno, et al.. (1995). Phase I study of NKT-01. Cancer Chemotherapy and Pharmacology. 36(3). 189–194. 5 indexed citations

2.

Majima, H, Shigeru Tsukagoshi, H Furue, et al.. (1993). [Phase I Study of RA-700. RA-700 Clinical Study Group].. PubMed. 20(1). 67–78. 5 indexed citations

3.

K, Ota, A Wakui, H Majima, et al.. (1992). [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].. PubMed. 19(6). 855–61. 30 indexed citations

4.

Ariyoshi, Y, A Wakui, H Niitani, et al.. (1992). [A phase I study of DWA2114R].. PubMed. 19(5). 685–93. 2 indexed citations

5.

Nakano, Kikuo, Ichiro Honda, H Majima, & Shuichi Fujimoto. (1991). A case of calcifying carcinoma of the stomach with long-term postoperative survival. Surgery Today. 21(3). 335–340. 1 indexed citations

6.

Majima, H. (1990). [Phase I clinical study of MX2 (KRN 8602)].. PubMed. 17(3 Pt 1). 359–64. 4 indexed citations

7.

Majima, H. (1989). [Present status of cisplatin (CDDP) analogues in Japan].. PubMed. 16(4 Pt 2-2). 1373–8. 3 indexed citations

8.

Kimura, Kiyoji, T Taguchi, I Urushizaki, et al.. (1987). Phase I study of recombinant human tumor necrosis factor. Cancer Chemotherapy and Pharmacology. 20(3). 223–229. 110 indexed citations

9.

Miura, Yuji, Shigeyuki Takeyama, A Wakui, et al.. (1987). Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(.BETA.-maltosyl)-1-nitrosourea (TA-077). III. Pharmacokinetics of a new nitrosourea antitumor agent TA-077 in humans (a phase I study).. Journal of Pharmacobio-Dynamics. 10(10). 523–527. 2 indexed citations

10.

Majima, H & Kensuke Ohta. (1987). Clinical studies of aclacinomycin A (ACM).. PubMed. 41(5). 233–7. 3 indexed citations

11.

Majima, H & Kotaro Nomura. (1986). [Phase I clinical study of MY-1, a new biological response modifier].. PubMed. 13(1). 109–15. 3 indexed citations

12.

Majima, H, et al.. (1986). [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].. PubMed. 13(3 Pt 1). 542–70. 11 indexed citations

13.

Maruyama, Keiichi, et al.. (1980). Effects of 1-Hexylcarbamoyl-5-fluorouracil (HCFU) and Its Metabolites on Bladder Movement. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 11(1). 27–36. 2 indexed citations

14.

Majima, H. (1980). Preliminary Clinical Study of Aclacinomycin A. Recent results in cancer research. 70. 75–81. 2 indexed citations

15.

Majima, H, et al.. (1972). BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.. PubMed. 56(6). 739–43. 4 indexed citations

16.

Torisu, Motomichi, et al.. (1967). C'3c deficient human sera with a beta-1c precipitin line.. PubMed. 99(3). 629–36. 7 indexed citations

17.

Torisu, Motomichi, et al.. (1967). C′3c Deficient Human Sera with a βlc Precipitin Line. The Journal of Immunology. 99(3). 629–636. 4 indexed citations

18.

Torisu, Motomichi, et al.. (1966). Low reactivity of human complement in health adults.. PubMed. 36(2). 251–3. 3 indexed citations

19.

Majima, H, et al.. (1966). Enzyme patterns in human tissues. IV. Comparison of glycolytic enzymes in surgical biopsies and autopsy specimens.. PubMed. 26(4). 607–11. 44 indexed citations

20.

Shonk, Carl E., et al.. (1964). ENZYME PATTERNS IN HUMAN TISSUES. II. GLYCOLYTIC ENZYME PATTERNS IN NONMALIGNANT HUMAN TISSUES.. PubMed. 24. 722–31. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact